BackTable Urology
Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay
Dr. Rana McKay
Yeah, I mean, absolutely. I think, you know, androgen deprivation therapy has been the backbone of systemic treatment for patients with prostate cancer for decades, has been and will likely continue to be just given the addiction of prostate cancer to the androgen receptor and androgen receptor signaling pathway.
0
💬
0
Comments
Log in to comment.
There are no comments yet.